C145H175ClN40O14S — CID 159628146
(E)-3-[4-[[[2-(6-amino-3-pyridinyl)-9-ethyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[(2-chloro-9-ethyl-6-morpholin-4-ylpurin-8-yl)methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-[4-(methanesulfonamido)phenyl]-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-(6-methoxy-3-pyridinyl)-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;4-[9-ethyl-8-[[methyl-[[4-[(E)-3-(methylamino)-3-oxoprop-1-enyl]phenyl]methyl]amino]methyl]-6-morpholin-4-ylpurin-2-yl]benzamide (PubChem CID 159628146) has the molecular formula C145H175ClN40O14S and a molecular weight of 2769.78 g/mol. Its IUPAC name is (E)-3-[4-[[[2-(6-amino-3-pyridinyl)-9-ethyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[(2-chloro-9-ethyl-6-morpholin-4-ylpurin-8-yl)methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-[4-(methanesulfonamido)phenyl]-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-(6-methoxy-3-pyridinyl)-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;4-[9-ethyl-8-[[methyl-[[4-[(E)-3-(methylamino)-3-oxoprop-1-enyl]phenyl]methyl]amino]methyl]-6-morpholin-4-ylpurin-2-yl]benzamide.
| Compound Name | (E)-3-[4-[[[2-(6-amino-3-pyridinyl)-9-ethyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[(2-chloro-9-ethyl-6-morpholin-4-ylpurin-8-yl)methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-[4-(methanesulfonamido)phenyl]-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-(6-methoxy-3-pyridinyl)-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;4-[9-ethyl-8-[[methyl-[[4-[(E)-3-(methylamino)-3-oxoprop-1-enyl]phenyl]methyl]amino]methyl]-6-morpholin-4-ylpurin-2-yl]benzamide |
|---|---|
| PubChem CID | 159628146 |
| Molecular Formula | C145H175ClN40O14S |
| Molecular Weight | 2769.78 g/mol |
| Exact Mass | 2767.36 |
| IUPAC Name | (E)-3-[4-[[[2-(6-amino-3-pyridinyl)-9-ethyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[(2-chloro-9-ethyl-6-morpholin-4-ylpurin-8-yl)methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-[4-(methanesulfonamido)phenyl]-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;(E)-3-[4-[[[9-ethyl-2-(6-methoxy-3-pyridinyl)-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]methyl]phenyl]-N-methylprop-2-enamide;4-[9-ethyl-8-[[methyl-[[4-[(E)-3-(methylamino)-3-oxoprop-1-enyl]phenyl]methyl]amino]methyl]-6-morpholin-4-ylpurin-2-yl]benzamide |
| SMILES | CCn1c(CN(C)Cc2ccc(/C=C/C(=O)NC)cc2)nc2c(N3CCOCC3)nc(-c3ccc(C(N)=O)cc3)nc21.CCn1c(CN(C)Cc2ccc(/C=C/C(=O)NC)cc2)nc2c(N3CCOCC3)nc(-c3ccc(N)nc3)nc21.CCn1c(CN(C)Cc2ccc(/C=C/C(=O)NC)cc2)nc2c(N3CCOCC3)nc(-c3ccc(NS(C)(=O)=O)cc3)nc21.CCn1c(CN(C)Cc2ccc(/C=C/C(=O)NC)cc2)nc2c(N3CCOCC3)nc(-c3ccc(OC)nc3)nc21.CCn1c(CN(C)Cc2ccc(/C=C/C(=O)NC)cc2)nc2c(N3CCOCC3)nc(Cl)nc21 |
| InChI | InChI=1S/C31H38N8O4S.C31H36N8O3.C30H36N8O3.C29H35N9O2.C24H30ClN7O2/c1-5-39-26(21-37(3)20-23-8-6-22(7-9-23)10-15-27(40)32-2)33-28-30(38-16-18-43-19-17-38)34-29(35-31(28)39)24-11-13-25(14-12-24)36-44(4,41)42;1-4-39-25(20-37(3)19-22-7-5-21(6-8-22)9-14-26(40)33-2)34-27-30(38-15-17-42-18-16-38)35-29(36-31(27)39)24-12-10-23(11-13-24)28(32)41;1-5-38-24(20-36(3)19-22-8-6-21(7-9-22)10-12-25(39)31-2)33-27-29(37-14-16-41-17-15-37)34-28(35-30(27)38)23-11-13-26(40-4)32-18-23;1-4-38-24(19-36(3)18-21-7-5-20(6-8-21)9-12-25(39)31-2)33-26-28(37-13-15-40-16-14-37)34-27(35-29(26)38)22-10-11-23(30)32-17-22;1-4-32-19(16-30(3)15-18-7-5-17(6-8-18)9-10-20(33)26-2)27-21-22(28-24(25)29-23(21)32)31-11-13-34-14-12-31/h6-15,36H,5,16-21H2,1-4H3,(H,32,40);5-14H,4,15-20H2,1-3H3,(H2,32,41)(H,33,40);6-13,18H,5,14-17,19-20H2,1-4H3,(H,31,39);5-12,17H,4,13-16,18-19H2,1-3H3,(H2,30,32)(H,31,39);5-10H,4,11-16H2,1-3H3,(H,26,33)/b15-10+;14-9+;12-10+;12-9+;10-9+ |
| InChIKey | MOTPADPEUVROEE-QUFPOAGRSA-N |
| XLogP | 14.54 |
| TPSA | 592.34 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 47 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 201 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2769.78 |
| LogP ≤ 5 | 14.54 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 47 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|